C07K 16/464
Igs containing cdr-residues from one specie grafted between fr-residues from another
Official title: {Igs containing CDR-residues from one specie grafted between FR-residues from another}
C07K16/464 (Igs containing cdr-residues from one specie grafted between fr-residues from another) appears on 272 US grants and 346 published applications in this corpus.
Search patents in C07K- Granted patents
- 272
- Published applications
- 346
- Assignees
- 185
- Inventors
- 511
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 2 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 2 | 0 |
| 1998 | 9 | 0 |
| 1999 | 12 | 0 |
| 2000 | 4 | 0 |
| 2001 | 5 | 0 |
| 2002 | 4 | 5 |
| 2003 | 4 | 10 |
| 2004 | 3 | 19 |
| 2005 | 4 | 16 |
| 2006 | 6 | 15 |
| 2007 | 6 | 13 |
| 2008 | 5 | 7 |
| 2009 | 6 | 19 |
| 2010 | 15 | 16 |
| 2011 | 8 | 23 |
| 2012 | 17 | 11 |
| 2013 | 18 | 33 |
| 2014 | 13 | 10 |
| 2015 | 19 | 13 |
| 2016 | 13 | 19 |
| 2017 | 12 | 15 |
| 2018 | 8 | 9 |
| 2019 | 3 | 10 |
| 2020 | 8 | 14 |
| 2021 | 8 | 13 |
| 2022 | 8 | 16 |
| 2023 | 12 | 10 |
| 2024 | 19 | 19 |
| 2025 | 8 | 5 |
| 2026 | 5 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methionine containing antibodies for conjugation of agents2 Jun 2026US 12,642,864 B2The Regents of the University of California
- Humanized antibodies with ultralong complementary determining regions21 Apr 2026US 12,606,937 B2Taurus Biosciences, LLC
- Anti-CEACAM5 antibodies and uses thereof10 Mar 2026US 12,570,761 B2Sanofi
- Compositions and methods for treating IgE-mediated disorders24 Feb 2026US 12,559,572 B2Xencor, Inc.
- Methods and compositions for treating staphylococcal infections20 Jan 2026US 12,528,882 B2The University of Chicago
- Methods and compositions for treating staphylococcal infections27 Aug 2026US 2026/0250425 A1The University of Chicago
- Bispecific binding agents for use in companion animals13 Aug 2026US 2026/0234262 A1Invetx, Inc.
- Novel anti-l1cam antibody4 Jun 2026US 2026/0152552 A1Curon Biopharmaceutical (Shanghai) Co., Limited
- Novel compositions and methods for treating ige-mediated disorders4 Jun 2026US 2026/0152574 A1Xencor, Inc.
- Construction method for humanized antibody sequence evaluation model and use thereof28 May 2026US 2026/0148804 A1Nanjing GenScript Biotech Co., Ltd.
Most cited
By later US patents
- Humanized immunoglobulins2,884US 5,585,089 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,259US 5,530,101 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,030US 5,693,762 AProtein Design Labs, Inc. · 1997
- Recombinant altered antibodies and methods of making altered antibodies1,968US 5,225,539 AMedical Research Council · 1993
- Humanized immunoglobulins and methods of making the same1,467US 6,180,370 B2Protein Design Labs, Inc. · 2001